Tzu‐Cheng Tsai, Shin‐Tarng Deng, Chao-Wei Hsu
Oct 22, 2019
Citations
0
Influential Citations
12
Citations
Quality indicators
Journal
Journal of Medical Virology
Abstract
Elbasvir/grazoprevir (EBR/GZR) is a new generation, fixed‐dose, combination antiviral drug used in chronic hepatitis C virus (HCV) genotype (GT) 1 or 4 infection. Our study evaluates the clinical efficacy and safety of EBR/GZR after its launch in Taiwan.